0001209191-23-031941.txt : 20230524
0001209191-23-031941.hdr.sgml : 20230524
20230524175131
ACCESSION NUMBER: 0001209191-23-031941
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230523
FILED AS OF DATE: 20230524
DATE AS OF CHANGE: 20230524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Callori Fred
CENTRAL INDEX KEY: 0001843393
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39971
FILM NUMBER: 23955315
MAIL ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Landos Biopharma, Inc.
CENTRAL INDEX KEY: 0001785345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815085535
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
BUSINESS PHONE: 540-818-2844
MAIL ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-23
0
0001785345
Landos Biopharma, Inc.
LABP
0001843393
Callori Fred
C/O LANDOS BIOPHARMA, INC.
PO BOX 11239
BLACKSBURG
VA
24062
1
0
0
0
0
Stock Option (right to buy)
0.33
2023-05-23
4
A
0
18000
0.00
A
2033-05-22
Common Stock
18000
18000
D
The shares subject to this option will vest and become exercisable on May 23, 2024, subject to the Reporting Person providing continuous service through such date.
/s/ Eric W. Blanchard, Attorney-in-Fact
2023-05-24